PSYCH 099: Functional Brain Imaging in Schizophrenia

Medlock Holmes enters the Hall of Living Minds.

Unlike the museum of structural imaging, nothing here is still. Every wall pulses with colour as thoughts ignite across the cortex. Memory glows, emotion flickers, attention surges, and language races through intricate neural pathways. Holmes is no longer examining anatomy-he is watching the brain at work.

His first instrument is functional magnetic resonance imaging (fMRI).

Unlike PET, which relies on radioactive tracers, fMRI detects changes in blood oxygenation (the BOLD signal), using local blood flow as an indirect marker of neuronal activity. Regions that become more active receive proportionally greater blood flow than oxygen consumption, producing measurable signal changes that can be mapped with remarkable spatial resolution. Arterial spin labelling (ASL) complements this by providing quantitative measurements of cerebral blood flow.

Holmes soon realises that schizophrenia is not characterised by a single inactive brain region.

Instead, the illness alters how entire neural systems coordinate their activity.

He begins with cognition.

Working memory, attention, executive function, verbal learning, and episodic memory consistently recruit the prefrontal cortex, hippocampus, parahippocampal gyrus, superior temporal cortex, and associated frontotemporal circuits. In schizophrenia, these networks often activate less efficiently. During memory encoding, reduced activation commonly appears within the inferior prefrontal cortex and hippocampal regions, while disrupted communication between frontal and temporal areas impairs the organisation of information required for later recall.

Holmes then follows the pathways rather than the individual regions.

Connectivity analysis transforms the investigation.

Instead of asking whether one area activates, investigators ask whether distant regions activate together. Functional connectivity, graph theory, and resting-state analyses reveal abnormalities within the default mode network, salience network, cognitive control network, and frontotemporal systems.

The mystery shifts from “Where is the lesion?” to “Which conversations have broken down?”

The investigation then turns toward emotion.

Patients are asked to identify facial expressions of happiness, sadness, fear, and anger while Holmes watches the amygdala.

Healthy brains recruit limbic structures in a carefully regulated manner.

Schizophrenia tells a different story.

Top-down cortical regulation is often diminished, yet threat-related stimuli such as fearful or angry faces provoke exaggerated bottom-up amygdala activation. Ironically, the stronger the amygdala response, the more likely patients are to misidentify the emotion. Increased amygdala activation also correlates with greater affective flattening and impaired social functioning, suggesting that emotional salience overwhelms cortical interpretation.

Holmes watches another experiment unfold.

Participants perform “oddball” attention tasks in which rare target stimuli must be distinguished from distracting novel events.

Healthy participants efficiently suppress irrelevant information.

Patients with schizophrenia instead demonstrate diffuse cortical hypofunction for targets alongside excessive activation to distracting stimuli. The brain appears to devote disproportionate resources to unexpected bottom-up events while failing to sustain the top-down control necessary for efficient cognition.

The investigation then expands beyond established illness.

Young people at clinical high risk for psychosis enter the scanner.

Their brains already resemble early schizophrenia.

During working-memory tasks they show reduced dorsolateral prefrontal activation, while emotional tasks reveal heightened bilateral amygdala responses. Resting-state studies identify dysconnectivity across default mode, cingulo-opercular, orbitofrontal, anterior cingulate, and medial temporal networks. Longitudinal studies suggest that individuals who later transition to psychosis fail to normalise these abnormal activation patterns over time.

Holmes next investigates treatment.

Can antipsychotics restore normal brain function?

Some studies suggest that second-generation antipsychotics increase dorsolateral prefrontal activity during working-memory tasks and partially normalise abnormal activation patterns. Pharmacological fMRI also explores how medications influence specific neural circuits, although separating medication effects from illness progression remains challenging.

Finally, genetics enters the observatory.

Researchers compare patients, unaffected siblings, and healthy controls.

Many unaffected relatives demonstrate milder versions of the same activation abnormalities, supporting the concept of functional imaging as an endophenotype. Studies examining genes such as COMT and GRM3 suggest that common genetic variants may subtly influence prefrontal and hippocampal activation, although individual genetic effects are generally small and require very large studies to detect reliably.

As Holmes prepares to leave, the entire observatory transforms into a vast network of glowing nodes joined by thousands of luminous pathways.

Some lines pulse brightly.

Others fade.

Some connect the wrong destinations.

He realises that schizophrenia is not merely a disease of damaged structures.

It is a disease of disturbed communication.

The anatomy provides the stage.

Functional imaging reveals the performance.

And the performance shows that the greatest mystery lies not within individual brain regions-but within the conversations that allow them to think together.

Key Takeaways

• Functional MRI (fMRI) is the principal tool for studying brain activity in schizophrenia.

• The BOLD signal measures changes in blood oxygenation as an indirect marker of neuronal activity.

• Arterial spin labelling provides quantitative measurements of cerebral blood flow.

• fMRI offers superior spatial and temporal resolution compared with PET for most cognitive studies.

• Schizophrenia is characterised by abnormal network function rather than isolated focal lesions.

• Working memory deficits commonly involve reduced dorsolateral and inferior prefrontal cortex activation.

• Memory encoding abnormalities involve disrupted hippocampal and frontotemporal activation.

• Executive dysfunction reflects impaired recruitment of prefrontal cognitive control networks.

• Functional connectivity analysis examines communication between distributed brain regions.

• Dysconnectivity affects default mode, salience, cognitive control, and frontotemporal networks.

• Frontotemporal connectivity abnormalities impair efficient verbal learning and memory organisation.

• Emotional processing studies consistently demonstrate abnormal amygdala activation.

• Threat-related facial expressions often produce exaggerated bottom-up amygdala responses.

• Increased amygdala activation may interfere with accurate emotional recognition and contribute to flat affect.

• Oddball attention paradigms reveal impaired top-down attention alongside excessive responses to distracting stimuli.

• Resting-state studies demonstrate widespread abnormalities in intrinsic brain network connectivity.

• Youth at clinical high risk for psychosis already exhibit abnormal prefrontal and amygdala activation patterns.

• Longitudinal imaging suggests persistent abnormalities predict transition to psychosis.

• Pharmacological fMRI may help evaluate how antipsychotic medications modify dysfunctional neural circuits.

• Functional imaging abnormalities are also observed in unaffected first-degree relatives, supporting their role as potential endophenotypes.

• Functional neuroimaging increasingly integrates with genetics, pharmacology, and precision psychiatry to better understand schizophrenia.